Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × Midazolam × Clear all

Sponsor

Conditions

Neoplasms 3 Melanoma 2 Lung Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Urothelial Cancer 1 Synovitis, Pigmented Villonodular 1 Solid Tumor 1 Skin Neoplasms 1 Rectal Neoplasms 1 Polyps 1 Patient Satisfaction 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Glioma 1 Diverticulosis, Colonic 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Carcinoma 1 Brain Neoplasms 1 Brain Diseases 1 Anxiety Disorders 1 Advanced Cancer 1

Interventions

vandetanib 7 lenvatinib 5 cabozantinib 4 Sunitinib 4 Sorafenib 4 AZD 6244 3 selpercatinib 2 durvalumab 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Paclitaxel 2 Iodine-131 2 Everolimus 2 Bortezomib 2 Axitinib 2 tremelimumab 1 tipifarnib 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 regorafenib 1 pralsetinib 1 ponatinib 1 perflutren 1 pazopanib 1 pasireotide 1 methyl N-acetylsibirosaminide 1 gallium 68 PSMA-11 1 fosbretabulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡